Patents by Inventor Concepción Nieto Magro

Concepción Nieto Magro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Progesterone intravaginal devices
    Patent number: 11278491
    Abstract: The invention relates to intravaginal devices, in particular rings, comprising progesterone in a particular polymorphic purity, methods for making such devices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polymorph I and are useful in the treatment of infertility in a female subject.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: March 22, 2022
    Assignee: ITF Research Pharma, S.L.U.
    Inventors: Concepción Nieto Magro, Elena Pérez Hernando, Jaime Moscoso Del Prado, Javier Suárez Almarza
  • PROGESTERONE INTRAVAGINAL DEVICES
    Publication number: 20210030666
    Abstract: The invention relates to intravaginal devices, in particular rings, comprising progesterone in a particular polymorphic purity, methods for making such devices and therapeutic uses of said devices. In particular, the intravaginal devices comprise a high amount of progesterone polymorph I and are useful in the treatment of infertility in a female subject.
    Type: Application
    Filed: March 21, 2019
    Publication date: February 4, 2021
    Applicant: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Concepción NIETO MAGRO, Elena PÉREZ HERNANDO, Jaime MOSCOSO DEL PRADO, Javier SUÁREZ ALMARZA
  • Treatment of vaginal atrophy in women with tumor pathology risk
    Patent number: 9114143
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: August 25, 2015
    Assignee: ITF RESEARCH PHARMA, S.L.U.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro
  • Treatment of vaginal atrophy in women with cardiovascular pathology risk
    Patent number: 8835414
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: September 16, 2014
    Assignee: ITF Research Pharma S.L.U.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro
  • TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH CARDIOVASCULAR PATHOLOGY RISK
    Publication number: 20110312929
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.
    Type: Application
    Filed: August 7, 2009
    Publication date: December 22, 2011
    Applicant: ITALFARMACO, S.A.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro
  • TREATMENT OF VAGINAL ATROPHY IN WOMEN WITH TUMOR PATHOLOGY RISK
    Publication number: 20110183950
    Abstract: The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor.
    Type: Application
    Filed: August 7, 2009
    Publication date: July 28, 2011
    Applicant: ITALFARMACO, S.A.
    Inventors: Álvaro Acebrón Fernández, Dolores Blanco Lousame, Jaime Moscoso Del Prado, Concepción Nieto Magro